300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Email
Payments
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Android
Internet
Sustainability
Hardware
Enterprise
Biotech
Impact
Community
Proptech
Transportation
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Dominican Republic
Middle East
Bermuda
Asia
Albania
Spain
Argentina
Bangladesh
Angola
Europe
Cyprus
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Qatar
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology VC Funds & Investors in Australia (August 2026)

The most active venture capital funds investing in Australia Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Australia Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Uniseed
VC Fund
27 Australia, United States, United Kingdom Series A, Seed, Series B Biotechnology, Manufacturing, Health Care $471k–$22M
Uniseed Ventures
VC Fund
18 Australia, United States, United Kingdom Series A, Seed Biotechnology, Health Care, Manufacturing $381k–$16M
Brandon Capital
VC Fund
18 Australia, United Kingdom, United States Series A, Seed, Series B Biotechnology, Health Care, Medical $673k–$81M
Artesian VC
VC Fund
13 Australia, United States, Hong Kong Seed, Series A, Pre-Seed Software, Artificial Intelligence, Health Care $70k–$15M
Main Sequence Ventures
VC Fund
11 Australia, United States, Philippines Seed, Series A, Series B Software, Artificial Intelligence, Manufacturing $1M–$72M
Medical Research Commercialisation Fund (MRCF)
VC Fund
10 Australia, United Kingdom, United States Series A, Seed Biotechnology, Health Care, Medical $1.3M–$13M
Stoic VC
VC Fund
8 Australia, United States, United Kingdom Seed, Series A Biotechnology, Medical, Health Care $600k–$16M
Melbourne Angels
VC Fund
7 Australia, United States, New Zealand Seed, Angel Biotechnology, Software, Information Technology $34k–$1.3M
Horizons Ventures
VC Fund
6 United States, United Kingdom, Canada Series A, Series B, Seed Biotechnology, Software, Artificial Intelligence $1M–$110M
Brisbane Angels
VC Fund
6 Australia, United States, New Zealand Seed, Pre-Seed, Series A Software, Information Technology, Health Care $200k–$19M
Flying Fox Ventures
VC Fund
6 Australia, New Zealand, United States Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $120k–$11M
Sydney Angels
VC Fund
5 Australia, United States Seed, Angel, Pre-Seed Software, SaaS, Health Care $120k–$1.5M
Australian Medical Angels
VC Fund
5 Australia, Hong Kong, Singapore Seed, Pre-Seed, Series A Health Care, Medical, Software $7k–$3.5M
Clean Energy Finance Corporation
VC Fund
4 Australia, United States, United Kingdom Debt Financing, Series B, Post-IPO Debt Energy, Renewable Energy, Real Estate $3.9M–$719M
Breakthrough Victoria
VC Fund
4 Australia, United States, Philippines Seed, Venture - Series Unknown, Series A Health Care, Manufacturing, Biotechnology $500k–$35M
IP Group Australia
VC Fund
4 Australia, New Zealand Seed, Series A, Pre-Seed Biotechnology, Manufacturing, Renewable Energy $811k–$30M
Possible Ventures
VC Fund
4 Germany, United States, Australia Seed, Pre-Seed, Series A Software, Biotechnology, Information Technology $586k–$47M
Queensland Investment Corporation
VC Fund
3 Australia, United States Seed, Series A, Private Equity Software, Information Technology, FinTech $673k–$450M
Starfish Ventures
VC Fund
3 Australia, United States, Philippines Series A, Series B Software, Enterprise Software, Internet $2M–$18M
Grok Ventures
VC Fund
3 Australia, United States, Singapore Series A, Seed, Series B Renewable Energy, Energy, Software $808k–$151M
OneVentures
VC Fund
3 Australia, United States, Israel Series A, Debt Financing, Series B Software, Health Care, SaaS $1.2M–$29M
Vectr
VC Fund
3 United States, Hong Kong, Singapore Seed, Series A, Series B FinTech, Financial Services, Artificial Intelligence $950k–$70M
GBS Ventures
VC Fund
3 United States, Australia, United Kingdom Series B, Series A Biotechnology, Health Care, Medical Device $2.2M–$35M
Tin Alley Ventures
VC Fund
3 Australia, Philippines Pre-Seed, Seed, Series B Biotechnology, Medical, Software $430k–$2.9M
Yuuwa Capital
VC Fund
3 Australia Series A, Seed, Series B Biotechnology, Software, Analytics $131k–$6.4M
South Australian Venture Capital Fund
VC Fund
3 Australia Seed, Series B, Series A Health Care, Biotechnology, Internet of Things $1M–$26M
Tenacious Ventures
VC Fund
3 Australia, United States, New Zealand Seed, Pre-Seed, Series A Agriculture, AgTech, Biotechnology $896k–$49M
Development Bank of Wales
VC Fund
3 United Kingdom, Australia, United States Seed, Debt Financing Software, Health Care, Manufacturing $18k–$3.8M
QIC BioVentures
VC Fund
3 Australia Series A Medical, Health Care, Biotechnology
Radar Ventures
VC Fund
3 Australia, United States, New Zealand Seed, Series A, Venture - Series Unknown Biotechnology, Robotics, Health Care $1.8M–$30M
Investible
VC Fund
2 Australia, United States, Singapore Seed, Series A, Pre-Seed Software, SaaS, Information Technology $300k–$20M
Tenmile
VC Fund
2 Australia, United States, Canada Venture - Series Unknown, Series A, Seed Health Care, Biotechnology, Manufacturing $3M–$177M
Canaan Partners
VC Fund
2 United States, United Kingdom, Israel Series A, Series B, Series C Software, Biotechnology, Health Care $5M–$80M
Renew Pharmaceuticals
VC Fund
2 Australia Series A, Series B Health Care, Biotechnology, Medical Device $5.6M–$6M
Global Health Investment Fund (GHIF)
VC Fund
2 United States, India, Austria Series B, Series C Health Care, Biotechnology, Medical Device $4.5M–$18M
SOSV
VC Fund
2 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Catalio Capital Management
VC Fund
2 United States, Switzerland, Israel Series A, Series B Biotechnology, Health Care, Life Science $15M–$150M
Hostplus
VC Fund
2 Australia, United Kingdom, United States Series A, Series B, Series C Software, Biotechnology, Semiconductor $6.3M–$111M
The George Institute for Global Health
VC Fund
2 Australia Seed Biometrics, Health Care, Biotechnology
IP Group
VC Fund
2 United Kingdom, United States, Australia Seed, Series A Health Care, Biotechnology, Therapeutics $393k–$30M
Folklore Ventures
VC Fund
2 Australia, United States, New Zealand Seed, Series A Software, Information Technology, Apps $500k–$21M
M8 Ventures
VC Fund
2 Australia, United States Pre-Seed, Seed, Series A Health Care, SaaS, Medical $200k–$8M
ALIAVIA Ventures
VC Fund
2 Australia, United States Seed, Pre-Seed, Series A Artificial Intelligence, Health Care, Information Technology $200k–$5.6M
Hitachi Ventures
VC Fund
2 United States, Australia, United Kingdom Series A, Series B, Series C Software, Artificial Intelligence, Information Technology $10M–$200M
Closed Loop Partners
VC Fund
2 United States, United Kingdom, Canada Seed, Series A, Debt Financing Recycling, Manufacturing, Waste Management $2M–$16M
Thistledown Foundation
VC Fund
2 Canada, Germany, Australia Series A, Seed Energy, Environmental Engineering, Laser $30M–$40M
Time Ventures
VC Fund
2 United States, Canada, Germany Series A, Series B, Seed Software, Information Technology, Artificial Intelligence $3.1M–$450M
BridgeLane Capital
VC Fund
2 Australia, Germany, United States Seed, Series A Software, Real Estate, Financial Services $673k–$6.1M
Monash University
VC Fund
2 Australia Series A, Seed Biopharma, Therapeutics, Biotechnology $17M–$19M
UniQuest
VC Fund
2 Australia, United Kingdom Seed, Series A, Series B Biotechnology, Water, Medical
Access all 338 VC funds in Australia Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Uniseed
VC Fund · Brisbane, Queensland, Australia · 27 investments in Australia Biotechnology startups, 7 in the past 12 months

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 86
  • Round size: Seed $600k–$3.5M; Series A $1.6M–$16M; Series B $471k–$22M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • DeteQt — Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Plasmaleap — Plasmaleap is a plasma technology company that manufactures and sells zero-emissions chemical reactors designed for industrial and energy applications. The company develops reactor systems that use plasma processes to enable chemical production and transformation without relying on conventional combustion methods. Its technology supports sectorssuch as clean fuels, chemical manufacturing, and materials processing by offering electrified reactor solutions that can be integrated into existing industrial workflows. Plasmaleap designs modular systems that allow operators to deploy plasma reactors for on-site production and conversion of feedstocks using electricity as the primary energy input. The company also provides engineering support and technical integration services to help customers incorporate its reactor technology into commercial operations. Through its plasma-based approach, Plasmaleap focuses on enabling chemical processes that align with decarbonization and emissions reduction objectives across multiple industries.
Show all investments...

Uniseed Ventures
VC Fund · Brisbane, Queensland, Australia · 18 investments in Australia Biotechnology startups

Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series A, Seed
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 57
  • Round size: Seed $381k–$4.2M; Series A $1.3M–$16M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2017

Portfolio highlights

  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Show all investments...

Brandon Capital
VC Fund · Melbourne, Victoria, Australia · 18 investments in Australia Biotechnology startups

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United Kingdom, United States

Investor stats

  • Total investments: 79
  • Round size: Seed $673k–$9.7M; Series A $5.2M–$81M; Series B $6.4M–$68M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $210M in 2019

Portfolio highlights

  • Longas — Longas Technologies, a Next Generation Sequencing (NGS) technology developer, has provided details on its Morphoseq™ library prep and associated software technology at the ‘Sequencing, Finishing and Analysis.
  • Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
  • Cincera Therapeutics — Cincera Therapeutics is a privately held biotechnology company.
Show all investments...

Artesian VC
VC Fund · Melbourne, Victoria, Australia · 13 investments in Australia Biotechnology startups

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, United States, Hong Kong

Investor stats

  • Total investments: 407
  • Round size: Seed $101k–$5M; Pre-Seed $70k–$1M; Series A $2.3M–$15M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • LivedCX® — LIVEDCX: Advanced AI technology for contact centre leaders who must simplify complexity to create growth.
  • Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
  • Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Show all investments...

Main Sequence Ventures
VC Fund · Sydney, New South Wales, Australia · 11 investments in Australia Biotechnology startups

We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Manufacturing
  • Stage:Seed, Series A, Series B
  • Geography: Australia, United States, Philippines

Investor stats

  • Total investments: 130
  • Round size: Seed $1M–$7M; Series A $4.5M–$30M; Series B $13M–$72M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — raised $303M in 2023

Portfolio highlights

  • Varden — FILM-FREE BARRIER COATING
  • Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
  • Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Show all investments...

Medical Research Commercialisation Fund (MRCF)
VC Fund · Melbourne, Victoria, Australia · 10 investments in Australia Biotechnology startups

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed
  • Geography: Australia, United Kingdom, United States

Investor stats

  • Total investments: 28
  • Round size: Series A $1.3M–$13M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • MycRx — MecRx is a drug development company that works on new treatments for cancer and novel mechanism of action antibiotics. Using proprietary “hit identification” technology, MecRx is developing inhibitors of cMyc, a protein that is deregulated in over 50% of all human cancers. MecRx draws on the expertise of the Peter MacCallum Cancer Centre and CSIROand is headquartered in Melbourne, Australia.MecRx was founded in 2013 by an ex-pharma/biotech team. MecRx is run as a virtual company based in Melbourne, Australia and its shareholders and service providers include the Peter MacCallum Cancer Institute and CSIRO. The company secured $5m Series A investment from the MRCF (www.mrcf.com.au) and CSIRO in 2015.
  • Currus Biologics — Currus Biologics develops BEAT technology to advance CAR T-cell therapy for solid tumors, aiming to improve treatment outcomes in oncology.
  • Cincera Therapeutics — Cincera Therapeutics is a privately held biotechnology company.
Show all investments...

Stoic VC
VC Fund · Sydney, New South Wales, Australia · 8 investments in Australia Biotechnology startups

Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Series A
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 24
  • Round size: Seed $600k–$4.2M; Series A $7.6M–$16M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
  • Lenexa Medical — Lenexa Medical is an Australian based MedTech company.
  • Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Show all investments...

Melbourne Angels
VC Fund · Melbourne, Victoria, Australia · 7 investments in Australia Biotechnology startups

Melbourne Angels is the most active startup investor in Victoria, one of the most active in Australia. Investing in start-ups since 2007, Melbourne Angels is committed to helping innovative founders build the next generation of our economy.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Information Technology
  • Stage:Seed, Angel
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 48
  • Round size: Seed $34k–$1.3M; Angel $219k–$918k
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Emanda — Thinking about selling your business in Australia? Emanda guides you through every step: business valuation, health check, corporate compliance, and sale process. Start with a business valuation.
  • Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
  • Bitwise Agronomy — Bitwise Agronomy uses AI to analyze crop video footage and provide growers with insights into crop health, growth, and yield potential.
Show all investments...

Horizons Ventures
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 6 investments in Australia Biotechnology startups

Investing in the deep science and technology that can propel humanity towards a radically better future.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 274
  • Round size: Seed $1M–$11M; Series A $6.2M–$47M; Series B $10M–$110M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Onavo — Onavo, founded 2010, is the company behind Onavo Insights, the largest mobile intelligence service, and the developer of the award-winning Onavo mobile utility apps.Onavo Insights market intelligence data, powered by fully anonymized data from Onavo's apps, powers business decisions in companies in verticals diverse as finance, gaming,entertainment and social networking, and reports are cited regularly in the press as the primary barometer of the mobile app ecosystem.
  • Magisto — Magisto online video editor is a fast & powerful video maker. Turn your photos and video clips into video stories with Magisto movie editor. Start free!
  • Corephotonics — Corephotonics is the pioneer and worldwide market leader of dual camera technologies for smartphones and mobile devices, providing a perfect mobile camera photography experience, novel photography features and superior image quality
Show all investments...

Brisbane Angels
VC Fund · Brisbane, Queensland, Australia · 6 investments in Australia Biotechnology startups

Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 81
  • Round size: Seed $250k–$1.5M; Pre-Seed $200k–$1.4M; Series A $2M–$19M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Giftbee — Giftbee reshapes gifting for businesses and consumers. Send gifts with flexibility to accept, swap, or give forward. Manage gifting programs, reduce waste, and create meaningful impact.
  • Indi — Indi supports parents’ mental well-being and helps them advocate for their children’s health.
  • Ovum — Meet Ovum, the intelligent health journal mobile app designed for womankind.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Flying Fox Ventures
VC Fund · Melbourne, Victoria, Australia · 6 investments in Australia Biotechnology startups

Flying Fox Ventures is an early stage investment firm that invests across industry and across the micro-stages of pre-seed and seed.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, New Zealand, United States

Investor stats

  • Total investments: 112
  • Round size: Seed $662k–$3.2M; Pre-Seed $120k–$3M; Series A $649k–$11M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Operata — Continuously measure performance to deliver the best possible customer experience.
  • SPEC Toolbox — Structural timber design software for Australian engineers. Design CLT, GLT, and connections to AS1720 standards. Start your free trial and automate today.
  • Teacher’s Buddy — Create lesson plans, worksheets, assessments, and more in minutes. AI-powered tools designed for educators.
Show all investments...

Sydney Angels
VC Fund · Sydney, New South Wales, Australia · 5 investments in Australia Biotechnology startups

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Australia, United States

Investor stats

  • Total investments: 97
  • Round size: Seed $120k–$1.5M; Angel $130k–$1.1M; Pre-Seed $337k–$1.5M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Keeyu — keeyu. is a B2B SaaS platform that continuously monitors e-commerce transactions from payment to delivery. Should any issue emerge, our system immediately notifies the customer service team, enabling proactive issue resolution before it impacts the customer, saving them from opening a support ticket. The result is an enhanced post-purchaseexperience, ensuring sales retention and reducing customer complaints.Founded in 2023, the company is headquartered in Sydney, Australia, and is dedicated to empowering businesses to deliver exceptional post-purchase experiences.
  • iiShield — iiShield aims to improve patient outcomes and surgeon training in transplant surgery by providing effective organ heat protection.
  • Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Show all investments...

Australian Medical Angels
VC Fund · 5 investments in Australia Biotechnology startups

Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia. In 2026, we

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, Hong Kong, Singapore

Investor stats

  • Total investments: 19
  • Round size: Seed $7k–$1.7M; Series A $3.3M–$3.5M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • GXE — At GXE, our mission is to build the all-in-one platform for unlisted assets and funds management. We provide investors, fund managers, and family offices with the tools they need to succeed and enable them to focus on their portfolios and investors whilst GXE takes care of everything else. A licensed financial services company, GXE holdsAustralian Financial Services Licence 460870 issued by the Australian Securities and Investments Commission. GXE welcomes clients across sectors including corporate, family offices, pension and superannuation fund managers, private equity, property, and venture capital.
  • Graphics et al. — Graphics et al. is a software that offers to create graphic designs. Graphics et al. mission is to make scientific communication easier.
  • Clean Slate Clinic — We are a for-purpose healthcare company focused on helping Australians keen to detox from alcohol, safely from home.
Show all investments...

Clean Energy Finance Corporation
VC Fund · Sydney, New South Wales, Australia · 4 investments in Australia Biotechnology startups

The Clean Energy Finance Corporation invests using a commercial approach to overcome market barriers and mobilize investment in renewable energy, energy efficiency, and low emissions technologies. They seek to catalyze and leverage private sector funding for the commercialization and deployment of clean energy technologies necessary for thetransition to a carbon-constrained economy.

Show more...

Investment focus

  • Industry: Energy, Renewable Energy, Real Estate
  • Stage:Debt Financing, Series B, Post-IPO Debt
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 137
  • Round size: Series B $3.9M–$77M; Post-IPO Debt $42M–$719M; Debt Financing $18M–$511M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $62M in 2018

Portfolio highlights

  • FlexiGroup — At FlexiGroup, we love to connect customers with things that will help them work and play. FlexiGroup is a diversified financial services group. Through a network of over 16,000 retail and business partners we provide a wide range of innovative finance products and payment solutions to consumers and businesses. From supporting education, toequipping a home, to building a business – we have a wide range of solutions to help. This includes interest free cards and no interest ever payment plans; consumer and business leasing solutions; and mobile and broadband plans. FlexiGroup operates in Australia, New Zealand and Ireland, and is offered at more than 16,000 locations including Harvey Norman, Escape Travel, IKEA, Domayne, Joyce Mayne, King Living, Nick Scali, Australian Outdoor Living, JB Hi-Fi, AGL Solar, The Good Guys Kitchens, Noel Leeming, Husqvarna, and the Fantastic Group.
  • Relectrify — Unlocking extra lifetime and performance of batteries via advanced battery management (BMS) technology.
  • Quintessential Equity — Owner-operator discipline across acquisition, improvement and operations. Tenant-first execution, governed decision-making and clear reporting for wholesale and professional investors. Explore the portfolio, capabilities and how we invest across cycles.
Show all investments...

Breakthrough Victoria
VC Fund · Melbourne, Victoria, Australia · 4 investments in Australia Biotechnology startups, 6 in the past 12 months

The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Biotechnology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Australia, United States, Philippines

Investor stats

  • Total investments: 55
  • Round size: Seed $708k–$6.8M; Series A $4M–$35M; Venture - Series Unknown $500k–$30M
  • Lead/follow: 53% lead, 47% follow

Portfolio highlights

  • AlleSense — AlleSense has developed a unique and novel solution to label-free imaging, the NanoMslide.
  • Mental Jam — We are a games studio dedicated to ​creating impactful experiences that ​explore mental health.
  • Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Show all investments...

IP Group Australia
VC Fund · Surry Hills, New South Wales, Australia · 4 investments in Australia Biotechnology startups

Ip Group Australia build and support outstanding intellectual property-based companies.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Renewable Energy
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, New Zealand

Investor stats

  • Total investments: 15
  • Round size: Seed $1.3M–$2.3M; Pre-Seed $811k–$896k; Series A $3M–$30M
  • Lead/follow: 47% lead, 53% follow

Portfolio highlights

  • MGA Thermal — MGA Thermal, specialists in thermal energy storage technology. Renewable, high-power, economical, modular, safe and sustainable thermal storage solutions.
  • Additive Assurance — Additive Assurance offers quality assurance for metal additive manufacturing.
  • Jetra Therapeutics — Jetra Therapeutics develops new treatment for obesity-related liver disease designed to reduce stress in liver cells.
Show all investments...

Possible Ventures
VC Fund · Munich, Bayern, Germany · 4 investments in Australia Biotechnology startups, 8 in the past 12 months

Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, United States, Australia

Investor stats

  • Total investments: 170
  • Round size: Seed $1.5M–$10M; Pre-Seed $586k–$3.5M; Series A $9.7M–$47M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Mkind — Mkind builds intelligent robots for high-mix manufacturing, developing advanced automation solutions that can adapt to diverse production requirements, improve operational efficiency, and support manufacturers in handling complex, low-volume, and frequently changing product lines.
  • Orbem — Transform biological imaging with AI-powered MRI technology. Non-invasive solutions for poultry, fruits, nuts, and health. Building a sustainable future.
  • Transition Metal Solutions — Transition harnesses wild microbial communities to recover copper and other critical metals from low-grade mining resources.
Show all investments...

Queensland Investment Corporation
VC Fund · Brisbane, Queensland, Australia · 3 investments in Australia Biotechnology startups

Queensland Investment Corporation is an investment company.

Show more...

Investment focus

  • Industry: Software, Information Technology, FinTech
  • Stage:Seed, Series A, Private Equity
  • Geography: Australia, United States

Investor stats

  • Total investments: 29
  • Round size: Seed $673k–$10M; Series A $3.6M–$10M; Private Equity $239M–$450M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $17M in 2022

Portfolio highlights

  • ModnPods — B2B modular manufacturing platform for multi-storey & hybrid developments across QLD & NSW. Backed by McNab. Accelerate builds by 50%.
  • Pacific Energy — Our innovative energy solutions are transforming the way power is generated, delivered, and managed across the nation.
  • Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Show all investments...

Starfish Ventures
VC Fund · Melbourne, Victoria, Australia · 3 investments in Australia Biotechnology startups

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

Show more...

Investment focus

  • Industry: Software, Enterprise Software, Internet
  • Stage:Series A, Series B
  • Geography: Australia, United States, Philippines

Investor stats

  • Total investments: 57
  • Round size: Series A $2M–$6.6M; Series B $2.5M–$18M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: May invest from a new fund soon — raised $134M in 2008

Portfolio highlights

  • CAP-XX — CAP-XX makes ultra-thin, high-power supercapacitors for portable and compact devices. Ideal for energy storage. Quotes & samples available.
  • Milkdrop — Introducing The Milkdrop Breast Pump Cushion. A Super Soft Silicone Cushion That Attaches To Your Breast Pump and Gently Moulds to Your Breast Making Pumping More Comfortable.
  • Smart Urban Properties Australia (SUPA) — Smart Urban Properties Australia (SUPA) offers a unique range of property solutions by bringing together renewable energy and mobility, super-speed fiber, and smart prop-tech. It is formed by bringing together Epsilon Security, b.energy, Fibrecorp, Smart Automation Systems, and connecX.
Show all investments...

Grok Ventures
VC Fund · Surry Hills, New South Wales, Australia · 3 investments in Australia Biotechnology startups

Backing a better tomorrow

Show more...

Investment focus

  • Industry: Renewable Energy, Energy, Software
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United States, Singapore

Investor stats

  • Total investments: 69
  • Round size: Seed $808k–$10M; Series A $3.3M–$63M; Series B $26M–$151M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Endolith — Endolith is a biotech company transforming sustainable mining by leveraging microbes, synthetic biology, and cloud computing to extract more critical minerals like copper from low-grade ores. Working with the many of the leading mining companies, Endolith is advancing its innovative technology to commercial scale. Recognized as a finalist in theBHP Unearthed BioMetals cohort and a member of the Alaska Critical Minerals Collaborative, Endolith is driving the future of mining with sustainable, efficient, and responsible solutions for the clean energy transition.
  • MAKO — Solving human problems with nature’s surfaces.
  • Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
OneVentures
VC Fund · Sydney, New South Wales, Australia · 3 investments in Australia Biotechnology startups

OneVentures is a later-stage venture capital firm focused on scaling Technology and Healthcare companies through growth equity and credit. The firm's role extends far beyond investment, as the firm actively guides companies toward achieving their next critical milestones. By leveraging decades of global experience and operational expertise,OneVentures accelerates growth and helps shape the future of its portfolio companies.A global growth focus drives their investment selection, with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

Show more...

Investment focus

  • Industry: Software, Health Care, SaaS
  • Stage:Series A, Debt Financing, Series B
  • Geography: Australia, United States, Israel

Investor stats

  • Total investments: 84
  • Round size: Series A $1.5M–$23M; Series B $13M–$29M; Debt Financing $1.2M–$14M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely still investing — raised $145M in 2022

Portfolio highlights

  • me&u — me&u is an online ordering and payment application designed to order meals. They provide communication technology to order and pay through mobile phones at restaurants. Their process of ordering with waiters and splitting bills that enable users to order their food and pay bills through a digital payment platform.
  • Truescope — Make better informed communications decisions with Truescope. Harnessing millions of media posts every day to deliver you real-time information that influences your business strategy.
  • Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Show all investments...

Vectr
VC Fund · Sheung Wan, Hong Kong Island, Hong Kong · 3 investments in Australia Biotechnology startups

Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Hong Kong, Singapore

Investor stats

  • Total investments: 79
  • Round size: Seed $950k–$6.5M; Series A $1M–$37M; Series B $12M–$70M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
  • Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
  • MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Show all investments...

GBS Ventures
VC Fund · Melbourne, Victoria, Australia · 3 investments in Australia Biotechnology startups

Founded in 1996, GBS invests in young businesses developing and commercialising products which, when combined with the right management and finance, will make a significant difference to patients' lives and deliver financial returns for their investors. Their areas of particular interest and expertise include human healthcare, biotechnologyproduct development and life science start-ups. In particular, recent investments have included biological or small molecule therapeutics, medical devices and diagnostics.GBS invests in private or public companies whether at start-up or later stages of company development. Their investors include major Australian superannuation funds.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical Device
  • Stage:Series B, Series A
  • Geography: United States, Australia, United Kingdom

Investor stats

  • Total investments: 41
  • Round size: Series A $2.2M–$9M; Series B $8.8M–$35M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Ivantis — Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development forthe treatment of other debilitating diseases within ophthalmology.
  • Moximed — Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis.
  • Elastagen — Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial. Elastin is a critical component of tissues in the human body which require the ability to stretch and recoil, such as the skin, lungs, arteries, elastic ligaments. Elastagen hasdeveloped a synthetic version of the elastin protein which is identical to that naturally present in the human body. Elastagen’s platform technology has potential applications in a number of areas including skin rejuvenation, scar remodelling and tissue repair. Elastagen was founded following the acquisition of intellectual property rights to the elastin technology which was developed by Prof Weiss at the University of Sydney. The Company has since successfully attracted capital from a number of leading Australian and overseas life science venture capital groups. Elastagen’s operations have expanded from its Australian base to include production in Europe and clinical operations in the UK.
Show all investments...

Tin Alley Ventures
VC Fund · Carlton, Victoria, Australia · 3 investments in Australia Biotechnology startups

Tin Alley Ventures collaborates with companies and researchers in the University of Melbourne's ecosystem to invest in & support world-changing businesses.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Pre-Seed, Seed, Series B
  • Geography: Australia, Philippines

Investor stats

  • Total investments: 7
  • Round size: Pre-Seed $430k–$2.9M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • i14 — We are i14 — we sit at the intersection of Computational Cognitive Science and AI research, and have developed a new class of models called Laplace Sequence Models that are an order of magnitude faster and more efficient and multiples more accurate than the transformer. We’ve also built a foundation model platform that allows organisations tocreate private, domain-specific expert models deployable across any environment (on-prem, at the edge, on device, in a private cloud, or hosted by i14). Our research lab continues to push beyond many of the limitations of current AI, and has a host of research projects which are continually integrated to update our foundation model platform. We recently closed a $4M initial round and are preparing for the next round.
  • Mirugen — Mirugen is a preclinical biotechnology company (re)programming cells to unlock innate cellular repair mechanisms.
  • Kronus — Full-stack development infrastructure for safety-critical systems.
Show all investments...

Yuuwa Capital
VC Fund · Perth, Western Australia, Australia · 3 investments in Australia Biotechnology startups

Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Analytics
  • Stage:Series A, Seed, Series B
  • Geography: Australia

Investor stats

  • Total investments: 16
  • Round size: Seed $131k–$808k; Series A $979k–$4.2M; Series B $2.6M–$6.4M
  • Lead/follow: 63% lead, 37% follow

Portfolio highlights

  • Nexgen Plants — Healthy plants, healthy people, living planet. Nexgen develop's plants for future generations that will improve the environment and health of future generations.
  • Icetana — icetana Motion Intelligence dramatically improves the active monitoring of security surveillance networks, with AI video anomaly detection and video analytics.
  • Agworld — Plan your crop, mitigate your risks, improve your profitability with Agworld farm management software.
Show all investments...

South Australian Venture Capital Fund
VC Fund · Adelaide, South Australia, Australia · 3 investments in Australia Biotechnology startups

South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Internet of Things
  • Stage:Seed, Series B, Series A
  • Geography: Australia

Investor stats

  • Total investments: 13
  • Round size: Seed $1M–$12M; Series A $2.3M–$20M; Series B $13M–$26M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Seonix Bio — Seonix Bio is dedicated to helping health professionals, individuals and researchers understand glaucoma risk using genetics.
  • Pearler.AI — Pearler gives your team super powers to respond fast to RFP, RFI, RFQ, Security, Cyber, Risk & Grant Questionnaires.
Show all investments...

Tenacious Ventures
VC Fund · Melbourne, Victoria, Australia · 3 investments in Australia Biotechnology startups

Tenacious Ventures - Australia's first and only dedicated agrifood tech VC firm.

Show more...

Investment focus

  • Industry: Agriculture, AgTech, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 24
  • Round size: Seed $1.1M–$10M; Pre-Seed $896k–$2.2M; Series A $5.9M–$49M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Nbryo — Contact Us for interest: contact@nbryo.com
  • Agovor — Agovor - Robotic towing machines to boost productivity while reducing your environmental footprint.
  • SwarmFarm Robotics — Global crop protection specialists ADAMA and Australian ag-tech company.
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 3 investments in Australia Biotechnology startups

Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Software, Health Care, Manufacturing
  • Stage:Seed, Debt Financing
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 248
  • Round size: Seed $360k–$3.3M; Debt Financing $18k–$3.8M
  • Lead/follow: 60% lead, 40% follow
  • Last fund: May invest from a new fund soon — raised $25M in 2018

Portfolio highlights

  • Wagonex — Car subscription is the new, all-inclusive, flexible alternative to leasing. No large downpayment and a single fixed monthly payment. Just add fuel and go.
  • Jehu Group — The Jehu Group is a third generation family owned business with over 80 years of successful trading history.We mange our operations on a day-to-day basis through three trading subsidiaries. Each subsidiary is supported by Jehu Group Limited which provides finance, HR, technical and procurement functions.In all of our markets, we position ourselvesas a dynamic and bespoke alternative to national contractors and house builders and are proud of our strong reputation in the market place.
  • Reacta Biotech — Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).
Show all investments...

QIC BioVentures
VC Fund · Brisbane, Queensland, Australia · 3 investments in Australia Biotechnology startups

QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A
  • Geography: Australia

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Verva Pharmaceuticals — Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) with those of obesity drug development company Adipogen Pharmaceuticals Pty Ltd. The combined productportfolio, technologies and expertise provide a substantial opportunity for rapid clinical progress and growth in high-value markets with a significant unmet medical need.Verva operates in a completely virtual mode, managed by a CEO and Directors with extensive international product development and partnering experience. Verva’s founding research was undertaken at the Metabolic Research Unit of Deakin University in Geelong, Australia; a state-of-the-art facility providing access to key in vitro and in vivo models and capabilities. Verva has subsequently engaged expert scientists, clinicians, technical advisers and contract research organisations worldwide to implement the Company’s research and development strategy.
  • Protagonist Therapeutics — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Show all investments...

Radar Ventures
VC Fund · 3 investments in Australia Biotechnology startups

Radar Ventures operates as an venture capital firm.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 21
  • Round size: Seed $1.8M–$11M; Series A $3.2M–$15M; Venture - Series Unknown $19M–$30M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Acumino — Acumino offers next-generation, AI powered robot models for the execution of highly dexterous tasks in industrial automation settings. The Acumino AI is trained on the most accurate data of robot interactions and facilitates the deployment of next-generation intelligent robot workers in a fast, scalable, reliable, cost-efficient manner, unlockingunmatched dexterity & ROI.
  • OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
  • Diag-Nose.io — Antibiotic resistance is rising to dangerously high levels in all parts of the world threatening our ability to treat common infectious diseases. Diag-Nose is working on a novel diagnostic tool to non-invasively distinguish between viral,bacterial and allergy-mediated sinusitis.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Investible
VC Fund · Sydney, New South Wales, Australia · 2 investments in Australia Biotechnology startups

Investible is an early-stage venture capital firm backing the visionaries advancing humanity through technology in Australia, New Zealand, Southeast Asia and globally.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, United States, Singapore

Investor stats

  • Total investments: 215
  • Round size: Seed $300k–$5.1M; Pre-Seed $392k–$2M; Series A $1.7M–$20M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • VoiceByte — VoiceByte is an application platform that allows its users to record and share their voice either privately or on social networks.
  • GeoSnapShot — Let's put your photos to work. Built for professionals, available to everyone. GeoSnapShot is loved by amateurs, professionals, teams and individuals.
  • Shore Trade — Buy Wholesale Seafood Directly from the Best Fisheries
Show all investments...

Tenmile
VC Fund · Perth, Western Australia, Australia · 2 investments in Australia Biotechnology startups

Tenmile invest quickly and confidently because it lacks the constraints that most venture capital funds.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: Australia, United States, Canada

Investor stats

  • Total investments: 20
  • Round size: Seed $7M–$8M; Series A $3M–$177M; Venture - Series Unknown $7.5M–$90M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • AdvanCell — AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies.
  • Syndeio Biosciences — Syndeio Biosciences is a clinical-stage biotechnology company focused on developing therapies to restore and enhance synaptic health in central nervous system (CNS) disorders.
  • Antares Therapeutics — Antares Therapeutics is a biotechnology company focused on developing transformational precision medicines targeting validated but previously undruggable targets in cancer and other serious diseases with significant unmet medical needs. Founded as a spin-out from Scorpion Therapeutics, it leverages proprietary drug discovery capabilities and arobust preclinical pipeline to advance multiple programs, primarily in precision oncology.
Show all investments...

Canaan Partners
VC Fund · Menlo Park, California, United States · 2 investments in Australia Biotechnology startups

Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 705
  • Round size: Series A $5M–$42M; Series B $8M–$80M; Series C $7.1M–$55M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $100M in 2024

Portfolio highlights

  • withco — Rebuilding main street, one share at a time.
  • Hermeus — Hermeus is developing hypersonic aircraft to connect the world faster than ever before.
  • GroundWork — GroundWork delivers Unified Monitoring for Real™ with an open software platform for shockingly easy integrations and customized visualizations of cloud, virtualization, network, application, server, and storage data.GroundWork Monitor is available in free (Core) and subscription versions with support (Enterprise).GroundWork was founded in 2004 andis headquartered in San Francisco, California with partners in Asia Pacific, Europe and South America.
Show all investments...

Renew Pharmaceuticals
VC Fund · 2 investments in Australia Biotechnology startups

Renew Pharmaceuticals is an healthcare company.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B
  • Geography: Australia

Investor stats

  • Total investments: 3
  • Round size: Series A $5.6M–$6M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Show all investments...

Global Health Investment Fund (GHIF)
VC Fund · New York, New York, United States · 2 investments in Australia Biotechnology startups

The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series B, Series C
  • Geography: United States, India, Austria

Investor stats

  • Total investments: 18
  • Round size: Series B $7.5M–$18M; Series C $4.5M–$14M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $108M in 2012

Portfolio highlights

  • Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
  • CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 2 investments in Australia Biotechnology startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Catalio Capital Management
VC Fund · Baltimore, Maryland, United States · 2 investments in Australia Biotechnology startups

Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B
  • Geography: United States, Switzerland, Israel

Investor stats

  • Total investments: 142
  • Round size: Series A $15M–$150M; Series B $26M–$130M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • OSPRI — Multiplex qPCR reagent kits for assay development, biomarker discovery, and translational research. 120+ configurations across a broad range of research areas. Extraction-free. Customizable. For Research Use Only.
  • Ratio Therapeutics — Ratio is a privately held discovery-stage biotechnology company that utilizes a suite of technologies licensed from Cornell University to develop best-in-class targeted radiotherapeutics for the treatment of metastatic cancers.
  • Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
Show all investments...

Hostplus
VC Fund · Melbourne, Victoria, Australia · 2 investments in Australia Biotechnology startups

Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!

Show more...

Investment focus

  • Industry: Software, Biotechnology, Semiconductor
  • Stage:Series A, Series B, Series C
  • Geography: Australia, United Kingdom, United States

Investor stats

  • Total investments: 63
  • Round size: Series A $6.3M–$49M; Series B $20M–$111M; Series C $13M–$60M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Emesent — Solutions for GPS-denied environments - delivering revolutionary efficiency, safety and operational insights to underground mining and other industries.
  • Gradiant — Gradiant is a solutions provider and developer of cleantech water projects for advanced water and wastewater treatment. They provide microelectronics, pharmaceuticals, food and beverage, lithium and key minerals, and renewable energy.
  • Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Show all investments...

The George Institute for Global Health
VC Fund · Sydney, New South Wales, Australia · 2 investments in Australia Biotechnology startups

The George Institute is on a mission to improve the health of millions of people worldwide. Join us in our fight for a healthier world.

Show more...

Investment focus

  • Industry: Biometrics, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Australia

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CellSync — CellSync is a Biotechnology Research firm that is working to make changes in the Future of Cell Engineering.
  • Sineva — Sineva is a medical device manufacturing firm that makes ultrasonography simulators.
  • Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 2 investments in Australia Biotechnology startups

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 206
  • Round size: Seed $393k–$8.5M; Series A $2.4M–$30M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $125M in 2014

Portfolio highlights

  • Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
  • Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
  • Oxa — Autonomous Vehicle Software - Any Vehicle, Any Place, Any Time
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Folklore Ventures
VC Fund · Sydney, New South Wales, Australia · 2 investments in Australia Biotechnology startups

Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.

Show more...

Investment focus

  • Industry: Software, Information Technology, Apps
  • Stage:Seed, Series A
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 51
  • Round size: Seed $698k–$5.5M; Series A $500k–$21M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Arkeus — Arkeus is a leader in the fusion of optics and autonomy. Our wide area autonomous optical systems are deployed to conduct Search, Intelligence, Surveillance and Reconnaissance in a range of operating environments.
  • Sphere — Live courses led by vetted experts for professionals who want to advance their careers
  • Octopusbot — Empowering agribusinesses with 97% accurate AI forecasts, 7 months ahead of the market to mitigate weather risk and price volatility.
Show all investments...

M8 Ventures
VC Fund · Sydney, New South Wales, Australia · 2 investments in Australia Biotechnology startups

M8 Ventures is a small, fast, pre-seed specialist venture fund focusing on the earliest stages of investment in the next generation of successful global tech companies from Australia and New Zealand. The firm was founded in 2018 and based in Sydney, New South Wales, Australia.

Show more...

Investment focus

  • Industry: Health Care, SaaS, Medical
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Australia, United States

Investor stats

  • Total investments: 11
  • Round size: Seed $2.9M–$8M; Pre-Seed $200k–$1M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
  • Emanda — Thinking about selling your business in Australia? Emanda guides you through every step: business valuation, health check, corporate compliance, and sale process. Start with a business valuation.
  • Flowing Bee — Revolutionise your customer interactions using AI, customer and behavioural insights. We create powerful marketing communications that drive behaviour change.
Show all investments...

ALIAVIA Ventures
VC Fund · Los Angeles, California, United States · 2 investments in Australia Biotechnology startups

Investing early in female-founded AI companies across the U.S. and Australia.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, United States

Investor stats

  • Total investments: 15
  • Round size: Seed $750k–$5.6M; Pre-Seed $200k–$1.3M; Series A $649k–$1.7M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Human Health — Human aims to assist medical professionals and patients to make more statistics selections.
  • InsightWise — Win more proposals and grants, and drive growth faster than ever.
  • GoFIGR — We are a talent insights and opportunity marketplace platform that helps you develop, engage and retain employees in the flow of work.
Show all investments...

Hitachi Ventures
VC Fund · München, Bayern, Germany · 2 investments in Australia Biotechnology startups

Official website of Hitachi, Ltd. Hitachi drives Social Innovation Business, creating a sustainable society with data and technology. We will solve customers' and society's challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series A, Series B, Series C
  • Geography: United States, Australia, United Kingdom

Investor stats

  • Total investments: 72
  • Round size: Series A $10M–$50M; Series B $21M–$100M; Series C $30M–$200M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Zenity — Zenity empowers enterprises to enable AI Agents securely. Our platform ensures adaptive security and governance from buildtime to runtime.
  • Arcee.ai — Learn how Arcee helps you build your own LLMs in your own cloud.
  • ClearOps — ClearOps is the AI-powered After Sales Platform connecting machinery OEMs, dealers and machines to improve spare parts availability, fill rates and machine uptime.
Show all investments...

Closed Loop Partners
VC Fund · New City, New York, United States · 2 investments in Australia Biotechnology startups

We Invest in the Circular Economy, a New Economic Model Focused on a Profitable and Sustainable Future.

Show more...

Investment focus

  • Industry: Recycling, Manufacturing, Waste Management
  • Stage:Seed, Series A, Debt Financing
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 47
  • Round size: Seed $2M–$7M; Series A $6M–$16M; Debt Financing $2.6M–$10M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $200M in 2022

Portfolio highlights

  • Supersede — Looking for sustainable lightweight waterproof plywood alternative. Upgrade your marine and construction projects with Supersede eco friendly materials.
  • TemperPack — Science-driven sustainable packaging for cold chain, food, pharma, pet and more. ClimaCell, Green Cell Foam and WaveKraft platforms. ISTA-certified.
  • Recycle Ann Arbor — Recycle Ann Arbor's mission is to develop and operate innovative reuse, recycling, and zero-waste programs.
Show all investments...

Thistledown Foundation
VC Fund · Ottawa, Ontario, Canada · 2 investments in Australia Biotechnology startups

Thistledown Foundation is a private charitable foundation.

Show more...

Investment focus

  • Industry: Energy, Environmental Engineering, Laser
  • Stage:Series A, Seed
  • Geography: Canada, Germany, Australia

Investor stats

  • Total investments: 6
  • Round size: Series A $30M–$40M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Avnos — Our HDAC solution offers the broadest geographic potential available, enabling our technology to operate in water-scarce environments.
  • Loam Bio — Loam has designed farmer-focused carbon projects that support farmers to build stable soil carbon in cropping and mixed farming systems.
  • Marvel Fusion — Marvel Fusion is a developer of fusion energy technology used to offer environment-friendly and safe energy. Its reactor is based on the short pulse, high energy, and electrically efficient laser that is suited for commercializing baseload fusion electrical power helping consumers to access clean, safe, and reliable energy sources.The company wasfounded in 2019 and is headquartered in Munich, Bayern.
Show all investments...

Time Ventures
VC Fund · California, Kentucky, United States · 2 investments in Australia Biotechnology startups

Time Ventures is an investment fund for Marc Benioff. The company looks to invest in theB2B, hospitality, non-financial services, and commercial products and services sectors.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, Germany

Investor stats

  • Total investments: 57
  • Round size: Seed $3.1M–$450M; Series A $10M–$80M; Series B $20M–$140M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Laurel — Time by Ping frees lawyers from timekeeping so they can focus on their work, and firms can understand where time is being spent.
  • June.ai — Discover June, a digital communication hub that replaces your email experience. June creates a new world for your existing email that gives you more control, interactivity and efficiency.
  • June — Transform enterprise system deployment with June. AI-driven implementation for Salesforce, Snowflake, SAP & more. No downtime, faster delivery, full control.
Show all investments...

BridgeLane Capital
VC Fund · Sydney, New South Wales, Australia · 2 investments in Australia Biotechnology startups

The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme

Show more...

Investment focus

  • Industry: Software, Real Estate, Financial Services
  • Stage:Seed, Series A
  • Geography: Australia, Germany, United States

Investor stats

  • Total investments: 20
  • Round size: Seed $673k–$4.2M; Series A $3M–$6.1M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • MadeComfy — Award-winning Airbnb management service in Australia and New Zealand. MadeComfy is a selected official partner of Airbnb. Find out how we earn you higher returns with short-term rentals.
  • Futurerent — Futurerent is a tool that offers solutions to residential property investors for investment capital and cashflow needs.
  • Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Show all investments...

Monash University
VC Fund · Clayton, Victoria, Australia · 2 investments in Australia Biotechnology startups

Monash University is an educational institution that offers undergraduate, graduate, and research courses in the fields of business, social sciences, science, and law. The schools of the university include Victorian College of Pharmacy, School of Nursing, and School of Applied Science.The university has a number of centers, five of which are inVictoria (Clayton, Caulfield, Berwick, Peninsula, and Parkville) and one in Malaysia. Monash also has a research and teaching center in Prato, Italy; a graduate research school in Mumbai, India; and a graduate school in Jiangsu Province, China.Monash University was founded in 1958 and is based in Melbourne, Australia.

Show more...

Investment focus

  • Industry: Biopharma, Therapeutics, Biotechnology
  • Stage:Series A, Seed
  • Geography: Australia

Investor stats

  • Total investments: 3
  • Round size: Series A $17M–$19M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • ElectraLith — The cleanest, most versatile and most cost-efficient method of extracting and refining lithium, the primary element of a sustainable future.
  • Atisama Therapeutics — Atisama Therapeutics is an Australian biotech company pioneering splice-switching oligonucleotide (SSO) therapies that restore normal gene transcription pathways to treat disease at the molecular level.
  • Inosi Therapeutics — Inosi Therapeutics develop therapies to address fibrosis.
Show all investments...

UniQuest
VC Fund · Brisbane, Queensland, Australia · 2 investments in Australia Biotechnology startups

UniQuest is a university commercializing and technology transfer company.

Show more...

Investment focus

  • Industry: Biotechnology, Water, Medical
  • Stage:Seed, Series A, Series B
  • Geography: Australia, United Kingdom

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • PERKii — PERKii Targeted Release Probiotics are naturally micro-shielded to resist stomach acid up to 10,000x stronger than non micro-shield probiotics. For a targeted release in your gut and a difference you can feel. PERKii Probiotic Drinks are bottled with one billion or more probiotics per serve.
  • Vicebio — Discover Sanofi's commitment to scientific innovation, our R&D focus areas, product pipeline, and digital approach to transforming the practice of medicine.
  • Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
Show all investments...

Biotechnology VC funding in Australia at a glance

Stats across 374 deals from 338 investors.

338
investors
in Australia Biotechnology startups
374
deals
in Australia Biotechnology startups
$3M
median round
in Australia Biotechnology startups
54%
lead investors
lead at least one round
24%
Grant
most common funding stage

Access all 338 VC funds in Australia Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology VC Funds in Australia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 338 VC funds investing in Australia Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists